Alexios Alexopoulos

Dr. Alexios Alexopoulos


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2013 in Pediatric Dermatology
Verified
Journal Article
Closed access
PDF file
AAAlexios Alexopoulos
Alexios Alexopoulos
TKTalia Kakourou
Talia Kakourou
IOIrene Orfanou
Irene Orfanou
AXAthina Xaidara
Athina Xaidara
GCGeorge Chrousos
George Chrousos

6 April 2015 in Pediatric Dermatology
Verified
Journal Article
Closed access
PDF file
AAAlexios Alexopoulos
Alexios Alexopoulos
TKTalia Kakourou
Talia Kakourou

29 April 2021 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
AAAlexios Alexopoulos
Alexios Alexopoulos
GCG. Chouliaras
G. Chouliaras
TKT. Kakourou
T. Kakourou
MDM. Dakoutrou
M. Dakoutrou
LNL. Nasi
L. Nasi
Athanasios MichosAthanasios Michos
Athanasios Michos

6 November 2017 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
AAAlexios Alexopoulos
Alexios Alexopoulos
ITI. Thanopoulou
I. Thanopoulou
MDM. Dakoutrou
M. Dakoutrou
EGE. Georgiadou
E. Georgiadou
GCG.P. Chrousos
G.P. Chrousos
TKT. Kakourou
T. Kakourou

19 September 2017 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
AAAlexios Alexopoulos
Alexios Alexopoulos
MDMaria Dakoutrou
Maria Dakoutrou
KSKalliopi Stefanaki
Kalliopi Stefanaki
GCGeorge Chrousos
George Chrousos
TKTalia Kakourou
Talia Kakourou

13 April 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
Evangelos FradelosEvangelos Fradelos
Evangelos Fradelos
KSKonstantinos Skampardonis
Konstantinos Skampardonis
Pavlos SarafisPavlos Sarafis
Pavlos Sarafis
AAAlexios Alexopoulos
Alexios Alexopoulos
ATAIKATERINI TOSKA
AIKATERINI TOSKA
FKFilippos Koinis
Filippos Koinis
Background: Chemotherapy-related symptom burden and psychological distress may significantly influence patients’ perceptions of treatment convenience and satisfaction, yet evidence in the Greek oncology population remains limited. Methods: A cross-sectional study was conducted among 150 cancer patients receiving chemotherapy in a tertiary hospital. Data were collected using CCSQ, ESAS-r, PHQ-2, GAD-2, and WHO-5. Pearson correlations and multiple linear regression analyses were performed. Results: Higher levels of depressive symptoms and anxiety were significantly associated with lower chemotherapy convenience and satisfaction (e.g., PHQ-2: r = −0.659 to −0.584, p < 0.001; GAD-2: r = −0.623 to −0.469, p < 0.001). Depressed mood emerged as a significant negative predictor of convenience (β = −0.39, p = 0.015) and concerns (β = −0.39, p = 0.005), while anxiety independently predicted satisfaction (β = 0.45, p = 0.007). Conclusions: Chemotherapy experience is strongly associated with psychological and symptom burden. These findings highlight the importance of integrating psychosocial assessment into routine oncology care.